PeptideStack
5.2kquestions
20kanswers
220users

My tirzepatide vial sat at 37 °C for fourteen days — is testing worth it before use?

Asked 12 Sept 2025Modified 11 months agoViewed 6.8k times
13

For reference: tirzepatide · 37 °C · fourteen days.

I am at the decision point and I would rather think it through than improvise.

I would rather spend money on measurement than on redundancy.

What does a sensible plan look like, and what are the decision points?

cold-chain
cold-chain

Keeping material within a temperature window from manufacture to use: phase-change packs versus dry ice, thermal mass, transit-lane temperature…

524 questionspeptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

832 questionsbatch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

865 questions
shareeditfollowflag
PT
askedpascal_thibault13k2712 Sept 2025
Related: the same reasoning applies to the counter-ion question. – Dr_Ravi_Selvarajah 3 months ago
add a comment

No answers yet

This question has not been answered. It has been viewed 6.8k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.